804 related articles for article (PubMed ID: 32798057)
1. Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison.
Vidyasagar K; Chandrasekar B; Chhabra M; Bhansali A; Bansal D
Clin Ther; 2020 Aug; 42(8):e115-e139. PubMed ID: 32798057
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
[TBL] [Abstract][Full Text] [Related]
3. Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.
Umpierrez GE; Jones S; Smiley D; Mulligan P; Keyler T; Temponi A; Semakula C; Umpierrez D; Peng L; Cerón M; Robalino G
Diabetes Care; 2009 Jul; 32(7):1164-9. PubMed ID: 19366972
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
[TBL] [Abstract][Full Text] [Related]
5. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
[TBL] [Abstract][Full Text] [Related]
6. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.
Umpierrez GE; Cuervo R; Karabell A; Latif K; Freire AX; Kitabchi AE
Diabetes Care; 2004 Aug; 27(8):1873-8. PubMed ID: 15277410
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials.
Lim BL; Lee WF; Lee B; Chung YEL; Loo KV
BMJ Open; 2023 Feb; 13(2):e070131. PubMed ID: 36764729
[TBL] [Abstract][Full Text] [Related]
8. Use of lispro insulin for treatment of diabetic ketoacidosis in dogs.
Sears KW; Drobatz KJ; Hess RS
J Vet Emerg Crit Care (San Antonio); 2012 Apr; 22(2):211-8. PubMed ID: 22390184
[TBL] [Abstract][Full Text] [Related]
9. Does Management of Diabetic Ketoacidosis with Subcutaneous Rapid-acting Insulin Reduce the Need for Intensive Care Unit Admission?
Cohn BG; Keim SM; Watkins JW; Camargo CA
J Emerg Med; 2015 Oct; 49(4):530-8. PubMed ID: 26238182
[TBL] [Abstract][Full Text] [Related]
10. Glargine versus regular insulin protocol in feline diabetic ketoacidosis.
Zeugswetter FK; Luckschander-Zeller N; Karlovits S; Rand JS
J Vet Emerg Crit Care (San Antonio); 2021 Jul; 31(4):459-468. PubMed ID: 33945208
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies.
Vincent M; Nobécourt E
Diabetes Metab; 2013 Sep; 39(4):299-305. PubMed ID: 23642642
[TBL] [Abstract][Full Text] [Related]
12. Use of lispro insulin for treatment of diabetic ketoacidosis in cats.
Malerba E; Mazzarino M; Del Baldo F; Corradini S; Carotenuto G; Giunti M; Fracassi F
J Feline Med Surg; 2019 Feb; 21(2):115-123. PubMed ID: 29513157
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children.
Cohen M; Leibovitz N; Shilo S; Zuckerman-Levin N; Shavit I; Shehadeh N
Pediatr Diabetes; 2017 Jun; 18(4):290-296. PubMed ID: 27005007
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis.
Ullal J; Aloi JA; Reyes-Umpierrez D; Pasquel FJ; McFarland R; Rabinovich M; Umpierrez GE
J Diabetes Sci Technol; 2018 Jan; 12(1):39-46. PubMed ID: 29291648
[TBL] [Abstract][Full Text] [Related]
15. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
Razavi Z; Maher S; Fredmal J
Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
[TBL] [Abstract][Full Text] [Related]
16. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression.
Musso G; Sircana A; Saba F; Cassader M; Gambino R
PLoS Med; 2020 Dec; 17(12):e1003461. PubMed ID: 33373368
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of NovoRapid infusion as a treatment option in the management of diabetic ketoacidosis.
Kwok R; Sztal-Mazer S; Hopkins RE; Poole SG; Grannell L; Coutsouvelis J; Topliss DJ
Intern Med J; 2017 Nov; 47(11):1317-1320. PubMed ID: 29105262
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
Pozzilli P; Battelino T; Danne T; Hovorka R; Jarosz-Chobot P; Renard E
Diabetes Metab Res Rev; 2016 Jan; 32(1):21-39. PubMed ID: 25865292
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial.
Thammakosol K; Sriphrapradang C
Diabetes Obes Metab; 2023 Mar; 25(3):815-822. PubMed ID: 36479786
[TBL] [Abstract][Full Text] [Related]
20. [Systematic review with meta-analysis: Subcutaneous insulin glargine coadministration for diabetic ketoacidosis].
Andrade-Castellanos CA; Colunga-Lozano LE
Gac Med Mex; 2016; 152(6):761-769. PubMed ID: 27861474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
